{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:58:48Z","timestamp":1648576728007},"reference-count":0,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1586\/14737140.8.4.507","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T04:04:36Z","timestamp":1207886676000},"page":"507-509","source":"Crossref","is-referenced-by-count":1,"title":["Potential new drug targets against hormone-dependent breast cancer identified"],"prefix":"10.1586","volume":"8","member":"301","published-online":{"date-parts":[[2014,1,10]]},"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737140.8.4.507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T12:25:19Z","timestamp":1481631919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737140.8.4.507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1586\/14737140.8.4.507"],"URL":"https:\/\/doi.org\/10.1586\/14737140.8.4.507","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}